{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:35:34Z","timestamp":1787924134293,"version":"build-2784847793"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.biopha.2024.117700","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T18:54:28Z","timestamp":1732128868000},"page":"117700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Population pharmacokinetics of unfractionated heparin and multivariable analysis of activated clotting time in patients undergoing radiofrequency ablation of atrial fibrillation"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-1613","authenticated-orcid":false,"given":"Celine","family":"Konecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-1691","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Lesaffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5798-2162","authenticated-orcid":false,"given":"Sophie","family":"Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1425-6368","authenticated-orcid":false,"given":"Florine","family":"Dubuisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1158-8062","authenticated-orcid":false,"given":"Moad","family":"Labdaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Faroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4022-7889","authenticated-orcid":false,"given":"Zoubir","family":"Djerada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117700_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2024.117700_bib2","doi-asserted-by":"crossref","first-page":"euae043","DOI":"10.1093\/europace\/euae043","article-title":"2024 European heart rhythm association\/heart rhythm society\/asia pacific heart rhythm society\/latin american heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.biopha.2024.117700_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/jce.12975","article-title":"Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: meta-analysis and meta-regression: anticoagulation for ablation of atrial fibrillation","volume":"27","author":"Briceno","year":"2016","journal-title":"J. ardiovasc Electro"},{"key":"10.1016\/j.biopha.2024.117700_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2165\/00003088-198005030-00002","article-title":"Clinical pharmacokinetics of heparin","volume":"5","author":"Estes","year":"1980","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2024.117700_bib5","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","article-title":"Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the american heart association","volume":"103","author":"Hirsh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.117700_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s40262-019-00751-7","article-title":"Revisiting the pharmacology of unfractionated heparin","author":"Derbalah","year":"2019","journal-title":"Clin. Pharm. [Internet]"},{"key":"10.1016\/j.biopha.2024.117700_bib7","article-title":"Development and validation of a nomogram model affecting the ACT targeting rate during radiofrequency ablation of atrial fibrillation in China","author":"Tang","year":"2023","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.biopha.2024.117700_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cvdhj.2023.11.001","article-title":"Evaluation of an adaptive, rule-based dosing algorithm to maintain therapeutic anticoagulation during atrial fibrillation ablation","volume":"4","author":"Kalscheur","year":"2023","journal-title":"Cardiovasc Digit Health J."},{"key":"10.1016\/j.biopha.2024.117700_bib9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.biopha.2024.117700_bib10","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2024.117700_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2024.117700_bib12","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2013.08.1623","article-title":"The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation","volume":"62","author":"Rold\u00e1n","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2024.117700_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/bja\/aex044","article-title":"Pharmacokinetic\/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass","volume":"118","author":"Delavenne","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.biopha.2024.117700_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/bcp.12930","article-title":"Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients: a PKPD model of unfractionated heparin in paediatric patients","volume":"82","author":"Al-Sallami","year":"2016","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2024.117700_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12967-015-0404-5","article-title":"Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery","volume":"13","author":"Jia","year":"2015","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.biopha.2024.117700_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2021.106553","article-title":"Robust K-PD model for activated clotting time prediction and UFH dose individualisation during cardiopulmonary bypass","volume":"214","author":"Chaux","year":"2022","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.biopha.2024.117700_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejps.2017.11.027","article-title":"Population pharmacokinetics of articaine with 1:200,000 epinephrine during third molar surgery and simulation of high-dose regimens","volume":"114","author":"Cazaubon","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117700_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/pharmaceutics12040380","article-title":"Real life population pharmacokinetics modelling of eight factors VIII in patients with severe haemophilia A: is it always relevant to switch to an extended half-life?","volume":"12","author":"Allard","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117700_bib19","unstructured":"Lavielle, M.; Chauvin, J. Rsmlx: R Speaks \u201cMonolix\u201d; Lixoft: Antony, France, 2019."},{"key":"10.1016\/j.biopha.2024.117700_bib20","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/pharmaceutics13081191","article-title":"External evaluation of population pharmacokinetic models and bayes-based dosing of infliximab","volume":"13","author":"Konecki","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117700_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115620","article-title":"A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis","volume":"168","author":"Geoffroy","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.117700_bib22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCEP.114.001586","article-title":"Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures","volume":"7","author":"Dillier","year":"2014","journal-title":"Circ. Arrhythm. Electro"},{"key":"10.1016\/j.biopha.2024.117700_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2014.10.005","article-title":"Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon","volume":"115","author":"Kaess","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2024.117700_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12872-021-02032-3","article-title":"Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.biopha.2024.117700_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1074248421998492","article-title":"Comprehensive intraprocedural unfractionated heparin protocol during catheter ablation of atrial fibrillation in the presence of direct oral anticoagulants and wide spectrum of body mass index","volume":"26","author":"Safani","year":"2021","journal-title":"J. Cardiovasc Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.117700_bib26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40262-023-01243-5","article-title":"Negative impact of ST-segment elevation myocardial infarction and morphine dose on ticagrelor uptake and pharmacodynamics: a population PK\/PD analysis of pooled individual participant data","volume":"62","author":"Konecki","year":"2023","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.biopha.2024.117700_bib27","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bjophthalmol-2021-318826","article-title":"New model to better diagnose dry eye disease integrating OCT corneal epithelial mapping","volume":"106","author":"Edorh","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2024.117700_bib28","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis [Internet]","article-title":"Multivariable Modeling Strategies","author":"Harrell","year":"2001"},{"key":"10.1016\/j.biopha.2024.117700_bib29","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis [Internet]","article-title":"Resampling, validating, describing, and simplifying the model","author":"Harrell","year":"2001"},{"key":"10.1016\/j.biopha.2024.117700_bib30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0","article-title":"Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets","volume":"19","author":"Steyerberg","year":"2000","journal-title":"Stat. Med"},{"key":"10.1016\/j.biopha.2024.117700_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection \u2013 A review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom. J."},{"key":"10.1016\/j.biopha.2024.117700_bib32","first-page":"185","article-title":"Higher initial weight-based heparin dosing is required with direct oral anticoagulants during catheter ablation for atrial fibrillation","volume":"58","author":"Payne","year":"2020","journal-title":"J. Inter. Card. Electro"},{"key":"10.1016\/j.biopha.2024.117700_bib33","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/europace\/euz057","article-title":"Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study","volume":"21","author":"Calkins","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.biopha.2024.117700_bib34","first-page":"278","article-title":"Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation","volume":"49","author":"Armbruster","year":"2015","journal-title":"Ann. Pharm."},{"key":"10.1016\/j.biopha.2024.117700_bib35","first-page":"91","article-title":"Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study","volume":"44","author":"Bin Abdulhak","year":"2015","journal-title":"J. Inter. Card. Electro"},{"key":"10.1016\/j.biopha.2024.117700_bib36","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2024.117700_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/pace.13013","article-title":"Determinants of heparin dosing and complications in patients undergoing left atrial ablation on uninterrupted rivaroxaban","volume":"40","author":"Enriquez","year":"2017","journal-title":"Pacing Clin. Electro"},{"key":"10.1016\/j.biopha.2024.117700_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cpt1979263294","article-title":"Forecasting individual pharmacokinetics","volume":"26","author":"Sheiner","year":"1979","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.117700_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5223(20)31420-3","article-title":"The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass","volume":"102","author":"Dietrich","year":"1991","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.biopha.2024.117700_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-5223(19)36215-4","article-title":"Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting","volume":"94","author":"Cloyd","year":"1987","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"10.1016\/j.biopha.2024.117700_bib41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-5223(19)37564-6","article-title":"Heparin resistance during cardiopulmonary bypass","volume":"85","author":"Esposito","year":"1983","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.biopha.2024.117700_bib42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF03005516","article-title":"Excessive requirement for heparin during cardiac surgery","volume":"28","author":"Chung","year":"1981","journal-title":"Can. Anaesth. Soc. J."},{"key":"10.1016\/j.biopha.2024.117700_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00000542-198110000-00020","article-title":"Increased heparin requirement with hypereosinophilic syndrome","volume":"55","author":"Hanowell","year":"1981","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopha.2024.117700_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4310407","article-title":"Preoperative low-molecular-weight heparin prophylaxis associated with increased heparin resistance frequency in on-pump coronary artery bypass graft surgery","volume":"2019","author":"Saydam","year":"2019","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.biopha.2024.117700_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(77)91429-5","article-title":"Heparin-induced decrease in circulating antithrombin-III","volume":"310","author":"Marciniak","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.117700_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0049-3848(81)90113-4","article-title":"Antithrombin III in patients treated with subcutaneous or intravenous heparin","volume":"22","author":"Conard","year":"1981","journal-title":"Thromb. Res"},{"key":"10.1016\/j.biopha.2024.117700_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF03022006","article-title":"Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery","volume":"54","author":"Bar-Yosef","year":"2007","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.biopha.2024.117700_bib48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejcts.2006.02.007","article-title":"Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively","volume":"29","author":"Pleym","year":"2006","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.biopha.2024.117700_bib49","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3390\/jcm10184240","article-title":"Running after activated clotting time values in patients receiving direct oral anticoagulants: a potentially dangerous race. results from a prospective study in atrial fibrillation catheter ablation procedures","volume":"10","author":"Benali","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2024.117700_bib50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/joa3.12357","article-title":"Coagulation and heparin requirements during ablation in patients under oral anticoagulant drugs","volume":"36","author":"Maury","year":"2020","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.biopha.2024.117700_bib51","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/jce.14260","article-title":"Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes","volume":"30","author":"Yamaji","year":"2019","journal-title":"J. Cardiovasc Electro"},{"key":"10.1016\/j.biopha.2024.117700_bib52","first-page":"277","article-title":"Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin","volume":"35","author":"Konduru","year":"2012","journal-title":"J. Inter. Card. Electro"},{"key":"10.1016\/j.biopha.2024.117700_bib53","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.hrthm.2015.04.016","article-title":"Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation","volume":"12","author":"Nagao","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.biopha.2024.117700_bib54","first-page":"551","article-title":"Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs","volume":"61","author":"Sairaku","year":"2021","journal-title":"J. Inter. Card. Electro"},{"key":"10.1016\/j.biopha.2024.117700_bib55","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3390\/jcm12062236","article-title":"Study of modifications induced by continued direct oral anticoagulant therapy during atrial fibrillation ablation procedures on standard hemostasis parameters","volume":"12","author":"Muller","year":"2023","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2024.117700_bib56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/jcm9020350","article-title":"Activated clotting time monitoring during atrial fibrillation catheter ablation: does the anticoagulant matter?","volume":"9","author":"Martin","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.biopha.2024.117700_bib57","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s00380-018-1294-2","article-title":"A novel protocol for initial heparin administration during catheter ablation for atrial fibrillation in patients taking direct oral anticoagulants","volume":"34","author":"Kishima","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.biopha.2024.117700_bib58","first-page":"154","article-title":"Influence of direct oral anticoagulants on anti\u2013factor Xa measurements utilized for monitoring heparin","volume":"52","author":"Macedo","year":"2018","journal-title":"Ann. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117700_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ijlh.13196","article-title":"The effect of DOACs on laboratory tests and their removal by activated carbon to limit interference in functional assays","volume":"42","author":"Exner","year":"2020","journal-title":"Int. J. Lab Hematol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224015865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224015865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:15:41Z","timestamp":1787922941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224015865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"alternative-id":["S0753332224015865"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117700","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics of unfractionated heparin and multivariable analysis of activated clotting time in patients undergoing radiofrequency ablation of atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117700"}}